Clark Estates Inc. NY reduced its position in shares of Amdocs Limited (NASDAQ:DOX – Free Report) by 7.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 37,300 shares of the technology company’s stock after selling 3,000 shares during the period. Clark Estates Inc. NY’s holdings in Amdocs were worth $3,263,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently bought and sold shares of DOX. Pzena Investment Management LLC grew its holdings in shares of Amdocs by 33.2% in the 2nd quarter. Pzena Investment Management LLC now owns 5,667,603 shares of the technology company’s stock worth $447,287,000 after acquiring an additional 1,412,826 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its position in shares of Amdocs by 36.6% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,175,790 shares of the technology company’s stock valued at $277,818,000 after purchasing an additional 851,022 shares during the period. Vanguard Group Inc. increased its stake in Amdocs by 39.5% in the 1st quarter. Vanguard Group Inc. now owns 2,033,536 shares of the technology company’s stock worth $183,771,000 after purchasing an additional 576,168 shares in the last quarter. Brandes Investment Partners LP lifted its stake in Amdocs by 31.1% during the second quarter. Brandes Investment Partners LP now owns 2,260,811 shares of the technology company’s stock valued at $178,335,000 after buying an additional 536,359 shares in the last quarter. Finally, Pacer Advisors Inc. boosted its holdings in shares of Amdocs by 36.2% in the second quarter. Pacer Advisors Inc. now owns 1,675,784 shares of the technology company’s stock worth $132,253,000 after buying an additional 444,966 shares during the period. 92.02% of the stock is currently owned by institutional investors.
Amdocs Price Performance
NASDAQ DOX opened at $87.37 on Wednesday. Amdocs Limited has a 1 year low of $74.41 and a 1 year high of $94.04. The company has a fifty day simple moving average of $88.06 and a 200 day simple moving average of $84.01. The company has a current ratio of 1.20, a quick ratio of 1.24 and a debt-to-equity ratio of 0.21. The company has a market cap of $10.27 billion, a P/E ratio of 20.61, a P/E/G ratio of 1.46 and a beta of 0.74.
Amdocs Dividend Announcement
Analysts Set New Price Targets
A number of research analysts have recently weighed in on the company. Oppenheimer lifted their price target on Amdocs from $98.00 to $105.00 and gave the company an “outperform” rating in a report on Wednesday, November 13th. Barclays lowered their target price on Amdocs from $113.00 to $111.00 and set an “overweight” rating on the stock in a research note on Thursday, November 14th. StockNews.com lowered shares of Amdocs from a “strong-buy” rating to a “buy” rating in a research report on Thursday, November 14th. Finally, Stifel Nicolaus assumed coverage on shares of Amdocs in a research report on Wednesday, October 2nd. They set a “buy” rating and a $100.00 price objective on the stock. One equities research analyst has rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $101.83.
About Amdocs
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Featured Stories
- Five stocks we like better than Amdocs
- How to Use Stock Screeners to Find Stocks
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- The Significance of Brokerage Rankings in Stock Selection
- 2 Generic Drug Stocks Ready to Surge in 2025
- Investing in Construction Stocks
- 3 Small-Cap Stocks That Are Ready to Rocket Higher
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.